BK Viremia and Viruria Does Not Depend on the Type of Double-J Stent Used During Kidney Transplantation

Exp Clin Transplant. 2024 Apr;22(4):267-269. doi: 10.6002/ect.2024.0037.

Abstract

Objectives: BK virus is a major cause of chronic renal allograft failure.Transplant ureteral stent use has been reported as a risk factorfor BK virus infection. Recently, the use of a new type of ureteral stent (Magnetic Black Star) was reported in kidney transplant recipients. The aim ofthis preliminary report was to compare BK virus viremia and viruria occurrence depending on the type of double-J stent (standard versus Magnetic Black Star).

Materials and methods: We included all kidney transplants performed in our center from January to December 2022. Each case had double-J stent placement. Indwelling stents were either a 6- or 7-Fr standard double-J stent or a 6-Fr Magnetic Black Star double-J stent. The type of double-J stent was chosen according to the surgeon's preference. A standard BK virus screening protocol was followed during the study period, which consisted of routine polymerase chain reaction examination of plasma and urine samples during monthly follow-ups.

Results: We assessed 120 patients without missing data: 92 patients received standard double-J stents and 28 patients received Magnetic Black Star stents. Patients were mostly male in the standard group (70.7%) versus the Magnetic Black Star group (42.9%) (P = .01). ABO- and HLA-incompatible transplant rates were similar in both groups. BK viremia occurrence and BK viruria occurrence were similar between groups at 1 month, 3 months, and 6 months.

Conclusions: This preliminary study showed no differences concerning BKvirus infection depending on the type of double-J stents used during kidney transplant.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • BK Virus* / immunology
  • BK Virus* / pathogenicity
  • Female
  • Humans
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Polyomavirus Infections* / diagnosis
  • Polyomavirus Infections* / immunology
  • Polyomavirus Infections* / urine
  • Polyomavirus Infections* / virology
  • Preliminary Data
  • Prosthesis Design*
  • Retrospective Studies
  • Risk Factors
  • Stents*
  • Time Factors
  • Treatment Outcome
  • Tumor Virus Infections* / diagnosis
  • Tumor Virus Infections* / immunology
  • Tumor Virus Infections* / urine
  • Tumor Virus Infections* / virology
  • Viremia* / diagnosis
  • Viremia* / virology